<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR38">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Halstenson</surname>
    <given-names>CE</given-names>
   </name>
   <name>
    <surname>Shamp</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Gargana</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Walsh</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Patchen</surname>
    <given-names>ML</given-names>
   </name>
  </person-group>
  <article-title>Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects</article-title>
  <source>Investig New Drugs</source>
  <year>2016</year>
  <volume>34</volume>
  <fpage>202</fpage>
  <lpage>215</lpage>
  <pub-id pub-id-type="doi">10.1007/s10637-016-0325-z</pub-id>
  <pub-id pub-id-type="pmid">26865390</pub-id>
 </element-citation>
</ref>
